Item 1A. Risk Factors
Item 1A. Risk Factors
Investing in our common stock involves a high
degree of risk. Before you invest you should carefully review our Management’s Discussion and Analysis of Financial Condition and
Results of Operations set forth in Item 2 of Part I of this Quarterly Report on Form 10-Q, our consolidated financial statements and related
notes included in Item 1 of Part I of this Quarterly Report on Form 10-Q and our consolidated financial statements and related notes,
as well as our Management’s Discussion and Analysis of Financial Condition and Results of Operations and the other information in
our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Readers should carefully review risks described in other documents
we file from time to time with the Securities and Exchange Commission.
We are currently
not in compliance with the Nasdaq continued listing requirements. If we are unable to regain compliance with Nasdaq’s listing requirements,
our securities could be delisted, which could affect our common stock’s market price and liquidity and reduce our ability to raise
capital.
The
Company received a notice (the “Initial Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC
(“Nasdaq”) on April 18, 2024 notifying the Company that due to the Company’s failure to timely file its Annual Report
on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”), with the SEC, the Company is not in compliance
with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely
filing of all required periodic reports with the SEC, and the Company subsequently received a notice (the “May Notice”) from
Nasdaq on May 21, 2024 due to the Company’s non-compliance with the Rule as a result of the Company’s failure to timely file
its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the “Form 10-Q”, together with the Form 10-K,
the “Delinquent Reports”). The May Notice states that the Company has until June 17, 2024 to submit to Nasdaq a plan to regain
compliance with the Rule.
On
June 26, 2024, the Company received a letter from Nasdaq indicating that, based on its further review and the plan of compliance submitted
by the Company on June 14, 2024, Nasdaq has determined to grant an exception to enable the Company to regain compliance with the Rule.
The terms of the exception are as follows: on or before October 14, 2024, the Company must file the Delinquent Reports, as required by
the Rule. In the event the Company does not satisfy the terms, Nasdaq will provide written notification that its securities will be delisted.
At that time, the Company may appeal Nasdaq’s determination to a hearings panel.
Subsequently,
on August 20, 2024, the Company received a notice (the “August Notice”) from Nasdaq indicating that, because the Company is
delinquent in filing its quarterly report on Form 10-Q for the period ended June 30, 2024, the Company is not in compliance with the Rule.
The Notice also indicates that as a result of this additional delinquency, the Company must submit an update to its original plan to regain
compliance with respect to the filing requirements. The Company has until September 4, 2024 to submit such update to Nasdaq.
The
August Notice has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Global Select Market.
While the Company can provide no assurance to the timing, the Company has submitted a letter to Nasdaq confirming that there has been
no change to its original plan to regain compliance with respect to the filing requirements, and will continue to work diligently to complete
and file its delayed SEC reports.
On
or before October 14, 2024, we must evidence compliance with the Rule, which requires the timely filing of all required periodic reports
with the SEC. If we fail to regain compliance with the Rule, or fail to evidence compliance with the Rule by October 14, 2024, we may
be subject to delisting. In that event, we would have the right to a hearing before a Nasdaq hearings panel, which would stay any suspension
or delisting action pending the conclusion of the hearing process and the expiration of any additional extension period granted by the
panel following the hearing.
We
cannot assure you that we will be able to regain compliance with Nasdaq listing standards. Our failure to continue to meet these requirements
would result in our common stock being delisted from Nasdaq, and if our common stock is delisted, our warrants will also be delisted.
We and holders of our securities could be materially adversely impacted if our securities are delisted from Nasdaq. In particular:
·
we may be unable to raise equity capital on acceptable terms or at all;
·
we may lose the confidence of our customers, which would jeopardize our ability to continue our business as currently conducted;
·
the price of our common stock will likely decrease as a result of the loss of market efficiencies associated with Nasdaq and the loss of federal preemption of state securities laws;
·
holders may be unable to sell or purchase our securities when they wish to do so;
·
we may become subject to stockholder litigation;
·
we may lose the interest of institutional investors in our common stock;
·
we may lose media and analyst coverage;
·
our common stock could be considered a “penny stock,” which would likely limit the level of trading activity in the secondary market for our common stock; and
·
we would likely lose any active trading market for our common stock, as it may only be traded on one of the over-the-counter markets, if at all.
Item 2. Unregistered Shares of Equity Securities and Use of Proceeds
None.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.